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recent publication, Akopyan et al. (2011) 
provide evidence challenging this canoni-
cal “one-step” model for the transport of 
effector proteins, proposing that in Yersinia 
pseudotuberculosis at least, a “two-step” 
model of T3SS-dependent protein trans-
location may be possible. In this “two-step” 
process, bacterial effectors are first secreted 
to the surface of the bacterium and then 
translocated across the host cell membrane 
in a T3SS-dependent manner.
Immunoelectron microscopy showed 
that Yersinia T3SS effectors YopE and YopH, 
and the translocator YopD are evenly dis-
tributed across the Yersinia surface prior 
to contact with host cells (Akopyan et al., 
2011). It is not uncommon for transloca-
tor proteins to be found on the bacterial 
surface (Ménard et al., 1994; Watarai et al., 
1996; Lara-Tejero and Galan, 2009), par-
ticularly since the hydrophilic translocator 
protein forms a tip at the end of the T3SS 
needle (Mueller et al., 2008). However, 
previous data employing immunofluo-
rescent microscopy indicated that effec-
tor proteins accumulated in the bacterial 
cytoplasm awaiting exit through the T3SS, 
and often exhibited polarized localization 
toward active T3SS needles (Schlumberger 
et al., 2005; Jaumouille et al., 2008; Winnen 
et al., 2008). Such data fits with a one-step 
T3SS translocation model where T3SS 
substrates are synthesized and stored in 
the bacterial cytoplasm ready to be fed to 
the T3SS basal body upon T3SS activation, 
with subsequent transport through the inte-
rior of the needle. While there is no direct 
evidence for effector transport through the 
needle, experiments have shown the need 
for effectors to unfold prior to secretion – 
indicative of transport though the needle 
core (Akeda and Galan, 2005). A one-step 
model would also explain how effectors 
can be translocated in a hierarchial man-
ner as has been shown for SipA, SopE, and 
SptP in Salmonella (Winnen et al., 2008; 
Lara-Tejero et al., 2011). Perhaps the most 
compelling evidence to support the current 
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Type three secretion systems (T3SSs) are 
macromolecular structures utilized by a 
number of bacterial pathogens to trans-
fer proteins from the bacterial cytosol, 
across bacterial and host membranes, 
into host cells (Cornelis, 2006). The proc-
ess of crossing the bacterial membranes is 
termed secretion with the steps of crossing 
the host membranes being called trans-
location. Once inside the host cells, the 
bacterial proteins subvert normal cellular 
processes to benefit the bacterium; the spe-
cific effect dependent on the infectious cycle 
of the bacterium. For example, Salmonella 
enterica uses effector proteins to remodel 
the host cell actin cytoskeleton and plasma 
membrane, mediating its uptake into non-
phagocytic cells (Ly and Casanova, 2007).
Type three secretion systems are highly 
conserved and consist of approximately 20 
proteins that assemble the basal body and 
needle components of a functional T3SS. 
The basal body is believed to carry out 
secretion and the hollow channel inside 
the needle structure is presumed to act 
as a conduit through which bacterial pro-
teins enter the host cell (Kubori et al., 1998; 
Marlovits et al., 2004; Cornelis, 2006). 
Although various models have been pro-
posed for the secretion apparatus, there is 
very little evidence detailing the translo-
cation mechanism. The current prevailing 
model is that the effectors transport from 
the needle tip across the host cell mem-
brane using bacterial proteins that create 
a translocon pore in the host cell mem-
brane (Hakansson et al., 1996; Scherer 
et al., 2000), thus completing secretion and 
translocation in a “one-step” process. In a 
“one-step” model is that most T3SS patho-
gens cannot be cross-complemented, that 
is, a mixed infection with mutants deficient 
in secretion and translocation separately 
will not restore the wild-type phenotype. 
Thus, the finding that functional effectors 
are present on the Yersinia surface and can 
be  translocated to induce physiological 
responses in host cells is surprising and 
requires reappraisal of the current data.
Akopyan et al. (2011) presented evidence 
that coating a Y. pseudotuberculosis yopH 
mutant with YopH in vitro restores the 
mutant to inducing a similar physiological 
response to wild-type bacteria. Furthermore, 
use of YopH-Bla or YopK-Bla hybrid pro-
teins to coat various Yersinia mutants led to 
the rapid, specific T3SS-specific transloca-
tion of the surface effectors into host cells. 
It is intriguing that surface effectors appear 
to be translocated in a manner similar to 
secreted effectors. It is still unclear how these 
surface effectors are transferred to the host 
cell membrane but it is clear that the trans-
locon remains important for their transfer 
inside the host cell; a Yersinia mutant lacking 
YopB and YopD failed to promote translo-
cation of a YopH-Bla coat, and the surface 
effectors require a translocation domain for 
transport inside the host cell (Akopyan et al., 
2011). This led the authors to propose that 
the translocon recognizes surface effectors 
via this domain and can then feed them 
into the host cell. This also explains why 
effectors possess such a domain. Hitherto, 
it was unclear why the translocon domain 
was required in addition to a secretion sig-
nal if the translocon acted as a continuation 
of the T3SS needle. This does not rule out 
the potential for the translocon to act as a 
checkpoint in T3SS secretion and ensure 
the smooth transition of effectors across 
the host cell membrane in both a one-step 
and two-step model. Indeed, relatively little 
is known as to how exactly the translocon 
functions, which could shed further light on 
the necessity of translocation domains in 
effector proteins. The additional finding that 
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bacteria in addition to elucidating the role 
of this process in infection. Hints may come 
from determining what proportion of effec-
tors are targeted to the bacterial surface, 
whether all effectors are represented on 
the surface and of course how these pro-
teins are transported to the surface. With 
the advancement in imaging technology, it 
is not impossible to speculate that we might 
be able to visualize both the secretion and 
the translocation process in the near future 
and to be able to demonstrate the “one-step” 
and/or “two-step” translocation beyond 
reasonable doubt.
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translocation supports the ability for T3SS 
substrates to be located on the bacterial sur-
face prior to their translocation in a T3SS 
manner (Akopyan et al., 2011). The pos-
session of both secretion and translocation 
sequences by T3SS effectors may indicate 
a flexibility in T3S hitherto unknown, and 
may suggest one-step and two-step trans-
location occur at the same time, although 
it is not clear yet what the advantage may 
be during infection.
One of the major questions this latest 
research poses is how universal two-step 
translocation is to other bacteria possess-
ing T3SSs. Initial experiments coating 
Salmonella Typhimurium with YopH-Bla 
constructs showed Salmonella was able 
to translocate YopH, in a SPI-1 T3SS-
dependent manner (Akopyan et al., 2011). 
A more definitive experiment would be to 
demonstrate whether such translocation 
could restore a biological phenotype, such as 
ruffling conferred by SopB or SopE during 
Salmonella infection. Given the homology 
that exists between components and effec-
tors of the Yersinia, Salmonella, and Shigella 
T3SSs (Rosqvist et al., 1995) it would not 
be surprising if the two-step translocation 
mechanism was used by each. Indeed, the 
Salmonella effector SptP has homology with 
both YopE and YopH (Kaniga et al., 1996) 
which would make it a likely candidate for 
two-step translocation. However, homology 
alone will not dictate that this translocation 
method is universal. The interactions of 
Yersinia, Salmonella, and Shigella with host 
cells leads to different outcomes, reflecting 
the different lifestyles led by these bacteria 
that have ultimately shaped their effector 
repertoire and may therefore potentially 
have individualized the function of their 
T3SSs. It will be necessary now to deter-
mine whether two-step translocation is 
universal to some or all T3SS-possessing 
